about
Local control of nuclear calcium signaling in cardiac myocytes by perinuclear microdomains of sarcolemmal insulin-like growth factor 1 receptorsMyocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model.Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study.Ischemia-reperfusion injury and pregnancy initiate time-dependent and robust signs of up-regulation of cardiac progenitor cells.Intentional ABO-incompatible heart transplantation: a case report of 2 adult patients.Sublethal caspase activation promotes generation of cardiomyocytes from embryonic stem cells.Myocardial recovery in peri-partum cardiomyopathy after continuous flow left ventricular assist device.In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Wnt/β-Catenin Stimulation and Laminins Support Cardiovascular Cell Progenitor Expansion from Human Fetal Cardiac Mesenchymal Stromal Cells.Immunogenicity of human embryonic stem cells.Whole organ and tissue reconstruction in thoracic regenerative surgery.Human fetal cardiac progenitors: The role of stem cells and progenitors in the fetal and adult heart.Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment.Mechanical isolation of the inner cell mass is effective in derivation of new human embryonic stem cell lines.Depressed expression of angiogenic growth factors in the subacute phase of myocardial ischemia: a mechanism behind the remodeling plateau?Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium.Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart.The international translational regenerative medicine center.Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction.Percutaneous Fluoroscopic-Guided Endomyocardial Delivery in an Experimental Model of Left Ventricular Assist Device Support.Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism.Verification of cell viability in bioengineered tissues and organs before clinical transplantation.Estrogen receptors do not influence angiogenesis after myocardial infarction.Costimulation blockade induces tolerance to HESC transplanted to the testis and induces regulatory T-cells to HESC transplanted into the heart.Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel.Emergency parallel mechanical circulatory support for ventricular fibrillation.HeartWare left ventricular assist device thrombosis in aspirin non-responder.Modulation of ephrinB2 leads to increased angiogenesis in ischemic myocardium and endothelial cell proliferationAngiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarctionAngiogenic and cardiac functional effects of dual gene transfer of VEGF-A165 and PDGF-BB after myocardial infarctionErythropoietin has an antiapoptotic effect after myocardial infarction and stimulates in vitro aortic ring sproutingSurgical closure of patent foramen ovale in patients with suspected paradoxical embolism: long-term resultsExtracorporeal membrane oxygenation as a rescue of intractable ventricular fibrillation and bridge to heart transplantationEarly first trimester human embryonic cardiac Islet-1 progenitor cells and cardiomyocytes: Immunohistochemical and electrophysiological characterizationPeripheral extracorporeal membrane oxygenation as short-term right ventricular support after HeartWare left ventricular assist device implantationCompared with matched controls, patients with postoperative atrial fibrillation (POAF) have increased long-term AF after CABG, and POAF is further associated with increased ischemic stroke, heart failure and mortality even after adjustment for AF
P50
Q28570893-FE52AD86-9C22-4402-8A4B-A8B208464694Q33264981-F5F40984-720A-4231-8492-747F317D6EA5Q34236181-A613CECD-BF18-4F87-94AE-5F70A4F2C167Q34271019-E9804146-CFDF-4FFA-9353-FD257E8A79FDQ34308803-35F5331F-CD3B-4320-B1A2-3C2768F53028Q35575643-049700BD-CC69-4955-835C-5E7009F1D446Q35666698-36D59E4C-EBE3-450E-A3CB-E4C5A4B2FADBQ36067836-C48CBFDC-842C-489A-B0A5-52887458BD2EQ36805043-984DEEFF-3A1A-479D-9AEA-D9F67F967DE2Q36936814-256CCE06-679A-49BE-9D6E-984C28974A0BQ38147406-42BE9DF5-294D-4FCE-B19D-E5EDFDDC377EQ38595644-B18AE3F9-4C41-47E9-8B2A-74E0B9725B4EQ39030556-36C698D1-839A-4428-85B0-2E11CDD11508Q40062817-8D88BE96-DD05-4D4A-81F1-713CC5203C19Q43218069-ACBDAF12-DCCA-4283-9CF2-D9196C50C110Q44872746-8D21EB96-6ECB-4F53-8B6A-4BCE4751CB7BQ45887364-EF9EFACE-F4A0-4E8F-91D1-B56BC77E754CQ46246942-B65528FA-3708-42C9-B75C-3D98C8D22C27Q48035047-7F3AFFA8-3B61-4190-9757-DACC5870643EQ50212420-AD13BF71-327D-499E-89E5-59223CE5EAC4Q50783983-6D2305F8-04C9-48F4-A020-9B9CD97EB218Q51247897-7561261D-1D47-4362-B52C-28B766592613Q52609973-5433818A-1949-427E-BF4C-658714E6188CQ53478474-99FC9A15-3C15-4BA1-A1C6-4291F14459E8Q53629452-8AC055C2-1115-428F-A858-84FD10B2B2C5Q53635216-80F62239-0FB2-4247-9216-442A61A74C04Q54293661-002E07D5-5CF5-4C8B-B2B2-2BA715714E46Q60721103-5DE365D6-8058-4E2B-AAD0-A60951A9D9ABQ80269916-9ED9E5DB-0457-4D52-B975-7D912D3A2F5EQ80457078-DF928B7F-5B98-4010-A221-A1A9200F1612Q81097381-DC463391-E318-4494-BDFE-55EA66D7AAEDQ81604342-003B86FD-42BE-49F6-B914-08300E2E5D81Q82906692-BE55F6D3-E58A-4185-A833-2F53D62C527FQ84864411-12435D95-AA60-45BA-AC87-E3C5B8933DCEQ87091434-C1F58728-88ED-4533-A23E-6B1DF96A1806Q89612399-1D36A538-383A-4459-AC14-C304F9FD417C
P50
description
onderzoeker
@nl
surgeon and researcher
@en
name
Karl-Henrik Grinnemo
@en
Karl-henrik Grinnemo
@ast
Karl-henrik Grinnemo
@es
Karl-henrik Grinnemo
@nl
Karl-henrik Grinnemo
@sl
type
label
Karl-Henrik Grinnemo
@en
Karl-henrik Grinnemo
@ast
Karl-henrik Grinnemo
@es
Karl-henrik Grinnemo
@nl
Karl-henrik Grinnemo
@sl
prefLabel
Karl-Henrik Grinnemo
@en
Karl-henrik Grinnemo
@ast
Karl-henrik Grinnemo
@es
Karl-henrik Grinnemo
@nl
Karl-henrik Grinnemo
@sl
P214
P5587
P906
P1153
6507007286
P21
P214
P31
P496
0000-0001-6717-3393
P5587
nl0378361lkkdsc
P569
1971-01-01T00:00:00Z
P7859
viaf-14755124